J&J gains after report says Apollo in talks for company's orthopedics unit
JNJ•Orthopedics unit faces litigation
** The unit generated $9.3 billion in 2025 but has faced thousands of lawsuits tied to its hip replacement devices
Analyst view and stock performance
** Nineteen of 26 brokerages rate the stock "buy" or higher, seven "hold"; their median PT is $282 — LSEG-compiled data
** Up to last day's close, the stock is up 28.3% YTD
Shares rise on report of Apollo talks
** Johnson & Johnson's JNJ.N shares up 1.3% at $268.96 in premarket trading
** Apollo Global Management APO.N is in talks to acquire co's orthopedics unit in a deal that could value it at nearly $20 billion, Bloomberg News reported on Friday, citing sources
** An agreement could be reached within several weeks, the report said
